About Zee Laboratories Limited
Data last updated:
Zee Laboratories Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PLC061704. Its GSTIN is 02AAACZ1397A1ZR (Himachal Pradesh). The company holds 6 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹10.09 Cr. It was formerly known as Zee Herbal Laboratories Private Limited and Zee Herbal Laboratories Ltd. It is led by directors including Rajeev Mukul (Managing Director) and Deepak Bambha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 913 D – Mall Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹463.57 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹27.43 Cr (net margin 5.9%) and EBITDA of ₹43.79 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 13% over five years.
The company has about 417 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Zee Healthcare. As per MCA filings, the company has satisfied charges of ₹8.95 Cr on record. Court records list 236 cases involving the company, including 119 filed by the company and 118 filed against it; 84 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹3.2 Cr; the latest was in October 2014. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Syncom Formulations (India) Limited with revenue of ₹482.45 Cr. The company has 13 MSME Form 1 returns on record between 2015 and 2024, listing 1,667 overdue payments to 62 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zeelab.co.in.
Company details
Name history
Zee Laboratories has undergone 2 name changes throughout its history. The company was previously known as Zee Herbal Laboratories Private Limited, and Zee Herbal Laboratories Ltd. The current legal name is Zee Laboratories Limited.
| Company Name | Status |
|---|---|
| Zee Laboratories Limited | Current |
| Zee Herbal Laboratories Private Limited | Previous |
| Zee Herbal Laboratories Ltd | Previous |
Contact details
Zee Laboratories Limited's registered office is in Delhi, Delhi. Its website is zeelab.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address913 D – Mall Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zee Laboratories Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Zee Laboratories operates one associated brand: Zee Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Potato farming, grain marketing, and equipment services in Maine. | zeehealthcare.in |
Business activity
The main business activity of Zee Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zee Laboratories Limited, buy the company report.
Financials of Zee Laboratories Limited
FY 2024 filings availableZee Laboratories Limited reported revenue of ₹463.57 Cr (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 10% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zee Laboratories Limited, buy the company report.
Board of directors and KMP of Zee Laboratories Limited
Zee Laboratories Limited currently reports 10 directors and 1 key managerial person. 26 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Bambha | Director | 29 Jul 2019 | 7 Years 2 Months | Current |
| Aarzoo Sharma | Director | 29 Jul 2023 | 3 Years 2 Months | Current |
| Harish Chandra Pathak | Additional Director | Current | ||
| Dhananjay Kumar | Director | 19 Nov 2020 | 5 Years 11 Months | Current |
| Anil Mehta Also directs: Lanark Laboratories Pvt Ltd, Antek Drugs Private Limited | Director | 29 Jul 2019 | 7 Years 2 Months | Current |
| Ramandeep Also directs: Klokter Life Sciences Private Limited | Additional Director | 12 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Zee Laboratories Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syncom Formulations (India) Limited | ₹482.45 Cr (FY 2025) | 74.0% | Mumbai, Maharashtra, India | |||
| Karnataka Antibiotics and Pharmaceuticals Limited | ₹479.24 Cr (FY 2022) | 11.0% | Bangalore, Karnataka, India | |||
| Cachet Pharmaceuticals Private Limited | ₹478.02 Cr (FY 2025) | 6.0% | Patna, Bihar, India | |||
| Adcock Ingram Limited | ₹463.95 Cr (FY 2025) | 8.0% | Bangalre, Karnataka, India | |||
| Zee Laboratories Limitedthis company | ₹463.57 Cr (FY 2024) | ₹27.43 Cr | 5.9% | 10.0% | 417 | Delhi, India |
| Aristo Laboratories Private Limited | ₹461.43 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Fredun Pharmaceuticals Ltd | ₹456.27 Cr (FY 2025) | 31.0% | Mumbai, Maharashtra, India | |||
| Hab Pharmaceuticals and Research Limited | ₹448.72 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Zee Laboratories Limited, buy the company report.
Auditor
Zee Laboratories Limited is audited by Vipin Kumar Mool Chand & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vipin Kumar Mool Chand & Co. | FY 2023 | 036717N |
Shareholding
The shareholding of Zee Laboratories Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zee Laboratories Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jan 2015 | 10556352 | Icici Bank Limited | ₹4.95 Cr | Satisfied | |
| 25 Feb 2010 | 10215041 | State Bank of India | ₹4 Cr | Satisfied |
To see the full charge records of Zee Laboratories Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Zee Laboratories Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹3.2 Cr; the latest was in October 2014.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2010 | Funding round | ₹3.2 Cr | Investors: 3 individuals |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: Rajiv Mukul HUF, 2 individuals Seller: Prem Chand Ekagar HUF, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zee Laboratories Limited has 236 court cases on record: 119 filed by Zee Laboratories, 118 filed against it. 84 cases are pending and 152 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 153 | 74 | 64 |
| High courts | 82 | 43 | 20 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 236)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Pending |
| District court, Jaipur Metro I, Rajasthan | Civil miscellaneous application | Filed against the company by M/S Eumedica LLP | Pending |
| High Court | Court case (COMIP) | Filed against the company by Kilitch Drugs India Limited | Pending |
| High Court | Interim or miscellaneous application | Filed against the company by Kilitch Drugs (India) Limited | Pending |
| District court, Hamirpur, Himachal Pradesh | Appeal | Filed against the company by General Manager, Zee Laboratories Ltd. | Disposed |
To see the full case history of Zee Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Zee Laboratories Limited has 13 MSME Form 1 returns on record between 2015 and 2024, listing 1,667 overdue payments to 62 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 62)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Shree Biotech | |||
| Wave Plasto Packs | |||
| Designindya Advertising Limited | |||
| an individual supplier | |||
| Shubhtrisha Enterprises |
To see the full MSME payment records of Zee Laboratories Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Zee Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Asian Reclamation Private Limited | U25190DL1997PTC088697 |
To see the full group structure of Zee Laboratories Limited, buy the company report.
Employees & EPFO
Zee Laboratories Limited has a workforce of 417 employees on its EPFO records as of Apr 14, 2025, across 3 active EPFO establishments.
GST
Zee Laboratories has 6 GST registrations: 3 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACZ1397A1ZR | Himachal Pradesh | Active | 01 Jul 2017 |
| 06AAACZ1397A1ZJ | Haryana | Active | 01 Jul 2017 |
| 09AAACZ1397A1ZD | Uttar Pradesh | Active | 12 Sep 2024 |
To see the full GST registrations and return filing status of Zee Laboratories Limited, buy the company report.
Recent activity
Zee Laboratories Limited has 36 board changes on record since 1994: 10 appointments and 26 cessations. The latest: Gurjeet Kaur was appointed as Additional Director on 28 Nov 2025.
31 earlier events are in the company report.
Frequently asked questions
Zee Laboratories is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 September 1994 (32+ years old) and is registered under CIN U74899DL1994PLC061704.
Zee Laboratories has 11 current directors and KMP:
- Rajeev Mukul - Managing Director
- Deepak Bambha - Director
- Aarzoo Sharma - Director
- Harish Chandra Pathak - Additional Director
- Dhananjay Kumar - Director
- Anil Mehta - Director
- Ramandeep - Additional Director
- Dikshika Kamboj - Additional Director
- Praveen Kumar Mishra - Director
- Gurjeet Kaur - Additional Director
- Sat Pal Singh - Cfo
The latest financial statements of Zee Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Zee Laboratories is 02AAACZ1397A1ZR, registered in Himachal Pradesh. The company has 6 GST registrations in all, of which 3 are active and 3 are cancelled or inactive. Other active GSTINs include 06AAACZ1397A1ZJ (Haryana), 09AAACZ1397A1ZD (Uttar Pradesh).
The CIN (Corporate Identification Number) of Zee Laboratories is U74899DL1994PLC061704. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zee Laboratories has 236 court cases on record: 119 filed by the company and 118 filed against it. 84 are pending. Most are in the district courts.
Zee Laboratories was incorporated on 23 September 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Zee Laboratories has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹3.2 Cr; the latest was in October 2014.
The peers of Zee Laboratories by revenue are Syncom Formulations (India) Limited, Karnataka Antibiotics and Pharmaceuticals Limited, Cachet Pharmaceuticals Private Limited, Adcock Ingram Limited, Aristo Laboratories Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gurjeet Kaur was appointed as Additional Director on 28 Nov 2025. Ankur ceased to be Company Secretary on 16 Oct 2025. Dikshika Kamboj ceased to be Additional Director on 01 Sep 2025. Zee Laboratories has 36 board changes on record in total.
Zee Laboratories has 13 MSME Form 1 returns on record between 2015 and 2024, listing 1,667 overdue payments to 62 micro and small suppliers. The latest return was filed on 04 Jul 2024.
Zee Laboratories can be reached through the website zeelab.co.in. Its registered office is in Delhi, India.